Replies to post #72940 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

I would expect them to do a new dosage study for Parkinson's. Different disease and younger population may indicate a different dosage level..

My non-professional opinion, anyone with medical training have an opinion?